- 1. (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione
- [An enteric-coated formulation of ixabepilone, a semisynthetic analogue of epothilone B and a non-taxane tubulin inhibitor, with antineoplastic activity. Ixabepilone binds to and stabilizes tubulin molecules, thereby interfering with the dynamics of microtubule assembly/disassembly. This results in cell cycle arrest at G2-M phase and leads to apoptosis of fast growing tumor cells. This agent demonstrates antineoplastic activity against taxane-resistant cell lines. Compared to intravenously administered ixabepilone, the oral formulation is a less cumbersome way of administering this agent. ( NCI )] (UMLS (NCI) C1135132) Azaepothilone B;
Epothilone;
IXABEPILONE;
Oral Ixabepilone =Organic Chemical; Pharmacologic Substance ;
| - 3. S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S26
- (UMLS (HL7) C1549913) =Intellectual Product =Message structure;
|
home
